NSE filing, NSE: COHANCE. Summary written from the filing by ALFA Finder's alert engine.
Cohance Lifesciences Ltd: key numbers
- Share price
- ₹450.45
- Market cap
- ₹17,234 Cr
- Revenue (annual)
- ₹2,269 Cr
- Net profit (annual)
- ₹179.2 Cr
- P/E (TTM)
- 162.2×Sector 37.9×
- Promoter holding
- 57.48%-0.01% QoQ
- FII holding
- 7.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cohance Lifesciences Ltd
All →Cohance Lifesciences Board Meeting Date
Cohance Lifesciences will hold a board meeting on 6 November 2026 to approve Q2 and half-year results. The trading window stays closed until 9 November 2026.
Cohance Lifesciences Other Announcement
Cohance Lifesciences Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b), disclosing promoter and public shareholding data as of September 30, 2026.
Cohance Lifesciences Regulatory Approval
Cohance Lifesciences received Central Government approval for the appointment of Mr. Umang Vohra as Chairman and Group CEO.
Cohance Lifesciences Employee Stock Options
Cohance Lifesciences Ltd. approved the grant of 2,60,194 stock options under ESOP 2026 and 6,14,594 stock options under ESOP 2023 to eligible employees.
Cohance Lifesciences Management Change
Cohance Lifesciences appointed Mr. Abhimanyu Ojha as the new Chief Financial Officer and Key Managerial Personnel, effective October 12, 2026.
Cohance Lifesciences Other Announcement
Cohance Lifesciences received a voluntary ESG Rating of Crisil ESG 61 (Strong) from Crisil ESG Ratings. No capital or business event is involved.
Other results correction announcements
All →City Pulse Multiventures Results Correction
City Pulse Multiventures resubmitted its H1 results after fixing typos in balance-sheet figures. The changes are clerical, with no material impact.
Susan Electricals India Results Correction
Susan Electricals India Ltd resubmitted its standalone financial results and a revised auditor's report for the September 2026 quarter. The revision corrects a description regarding the reporting period.
Sumeet Industries Results Correction
Sumeet Industries files a corrected related party transactions statement for its Q1 FY27 integrated financial filing. The revision, filed under CIRP, is for information and record.
Polychem Results Correction
Polychem clarified its November 3, 2026 board outcome omitted unaudited Q2 and H1 results. Complete results were later uploaded under outcome, results and Reg 30 tabs.
Panth Infinity Results Correction
Panth Infracon corrected a clerical EPS error in its unaudited quarter and half-year results. Revised results were refiled with the corrected earnings per share figures.
One Mobikwik Systems Results Correction
MobiKwik corrected its consolidated Q2 and H1 FY27 EPS from ₹0.75 to ₹1.50 per share. The error was an incorrect PDF upload, with no financial impact.